Showing results (71-80 of 99) with videos related to
Sort By:
Pageof 10
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|November 27, 2019
Preventive tuberculosis treatment effect on QuantiFERON TB-Gold in-tube testing in a high tuberculosis-endemic country: A clinical trialQingluan Yang, Qiaoling Ruan, Xuefeng Liu, et al.Journal of Cellular and Molecular Medicine|November 9, 2020
Differential expression of CD64 in patients with Mycobacterium tuberculosis infection: A potential biomarker for clinical diagnosis and prognosisQianqian Liu, Yan Gao, Qinfang Ou, et al.Antimicrobial Agents and Chemotherapy|November 19, 2014
Evolution and transmission patterns of extensively drug-resistant tuberculosis in ChinaFeifei Wang, Lingyun Shao, Xiaoping Fan, et al.Microbiology Spectrum|December 1, 2022
<i>Mycobacterium tuberculosis</i> Infection among 1,659 Silicosis Patients in Zhejiang Province, ChinaQingluan Yang, Miaoyao Lin, Zhangyufan He, et al.Frontiers in Genetics|July 9, 2024
A rare missense p.C125Y mutation in the <i>TNFRSF1A</i> gene identified in a Chinese family with tumor necrosis factor receptor-associated periodic fever syndromeMengqing Qian, Jingyu Zhou, Jing Wu, et al.Plos One|December 29, 2012
Evaluation of the diagnostic potential of IP-10 and IL-2 as biomarkers for the diagnosis of active and latent tuberculosis in a BCG-vaccinated populationSen Wang, Ni Diao, Chanyi Lu, et al.Current Research in Microbial Sciences|March 9, 2026
A multi-glycoprotein synergized recombinant virus system resolved the research dilemma of Epstein-Barr virus entry and facilitated the development of entry-specific drugs or vaccinesTianyu Lu, Shufeng Tian, Jiapeng Luo, et al.Clinical and Vaccine Immunology : CVI|November 9, 2012
Mycobacterium tuberculosis region of difference (RD) 2 antigen Rv1985c and RD11 antigen Rv3425 have the promising potential to distinguish patients with active tuberculosis from M. bovis BCG-vaccinated individualsSen Wang, Jiazhen Chen, Ying Zhang, et al.Frontiers in Immunology|December 26, 2022
B21 DNA vaccine expressing ag85b, rv2029c, and rv1738 confers a robust therapeutic effect against latent <i>Mycobacterium tuberculosis</i> infectionShufeng Weng, Jinyi Zhang, Huixia Ma, et al.Emerging Microbes & Infections|August 16, 2020
Corticosteroid prevents COVID-19 progression within its therapeutic window: a multicentre, proof-of-concept, observational studyYang Li, Xian Zhou, Tao Li, et al.Pageof 10